Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea · Delayed Price · Currency is KRW 3,050.00
+65.00 (2.18%)
At close: Nov 13, 2026
Vivozon Pharmaceutical Market Cap
Vivozon Pharmaceutical has a market cap or net worth of 183.5 billion as of November 13, 2026. It is the 23,029th most valuable company in the world and the 866th biggest in South Korea. Its market cap has decreased by 19.84% in one year.
Market Cap
183.50B
Enterprise Value
206.27B
Revenue
50.34B
Global Rank
Country Rank
#866 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 18, 2005, Vivozon Pharmaceutical's market cap has increased from 72.45B to 183.50B, an increase of 153.28%. That is a compound annual growth rate of 4.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 183.50B | -8.56% |
| Dec 30, 2025 | 200.68B | -40.93% |
| Dec 30, 2024 | 339.73B | 134.89% |
| Dec 28, 2023 | 144.64B | -2.99% |
| Dec 29, 2022 | 149.09B | -19.87% |
| Dec 30, 2021 | 186.05B | -37.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 230.33B |
| DAE HWA Pharmaceutical | 174.09B |
| GC WellBeing | 170.58B |
| HEM Pharma | 164.37B |
| CellBion | 160.93B |
| NOVAREX | 151.04B |
| Kyung Dong Pharmaceutical | 144.01B |
| PHARMARESEARCH BIO | 117.06B |